Injectable conductive and angiogenic hydrogels for chronic diabetic wound treatment
Journal of Controlled Release, ISSN: 0168-3659, Vol: 344, Page: 249-260
2022
- 62Citations
- 52Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations62
- Citation Indexes62
- 62
- CrossRef7
- Captures52
- Readers52
- 52
Article Description
Chronic diabetic wounds are lack of angiogenesis and susceptible to bacterial infections due to their high sugar microenvironment, making them difficult to heal. Here, a conductive and intrinsically antibacterial hydrogel with pH responsiveness has been developed. This hydrogel has good mechanical properties, self-healing ability and biocompatibility, and can smartly release the pro-angiogenic drug, deferoxamine. Application of the hydrogel promotes the proliferation and migration of endothelial cells and enhances vascularization by upregulating the expression of hypoxia-inducible factor-1α and vascular endothelial growth factor. The hydrogel dressing combined with electrical stimulation improves angiogenesis and significantly accelerates the healing of infected diabetic wounds, which would lead to a promising therapeutic strategy.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0168365922001249; http://dx.doi.org/10.1016/j.jconrel.2022.03.014; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85126575881&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/35288167; https://linkinghub.elsevier.com/retrieve/pii/S0168365922001249; https://dx.doi.org/10.1016/j.jconrel.2022.03.014
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know